Skip to content

Clinical trials

Phase 3 Digestive System Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Neoplasms Phase: Phase 3 Country / region: South Korea Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20142
20162
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.2
Abbott1
Celgene1
Imunon1
Novartis Pharmaceuticals1
NuCana plc1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Neoplasms8
Neoplasms7
Digestive System Diseases6
Adenocarcinoma5
Neoplasms by Site5
Neoplasms by Histologic Type4
Neoplasms, Glandular and Epithelial4
Carcinoma2
Carcinoma, Hepatocellular2
Colonic Diseases2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.